塔蘇斯製藥公司
US ˙ NasdaqGS ˙ US87650L1035

SecurityTARS / Tarsus Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership67,161 shares
Latest Disclosed Value $ 2,720,692
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 6.56% increase in ownership of TARS / Tarsus Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 67,161 shares of Tarsus Pharmaceuticals, Inc. (US:TARS) valued at $2,720,692 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 63,024 shares of Tarsus Pharmaceuticals, Inc.. This represents a change in shares of 6.56% during the quarter. The current value of the position is $3,981,304 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Tarsus Pharmaceuticals EC US87650L1035 67,161 4,137 6.56 2,721 -15.97 0.0611
2025-05-28 2025-03-31 NP Tarsus Pharmaceuticals EC US87650L1035 63,024 999 1.61 3,238 -5.74 0.0777
2025-02-25 2024-12-31 NP Tarsus Pharmaceuticals EC US87650L1035 62,025 -10,835 -14.87 3,434 43.32 0.0750
2024-11-26 2024-09-30 NP Tarsus Pharmaceuticals EC US87650L1035 72,860 17,092 30.65 2,396 58.15 0.0453
2024-08-26 2024-06-30 NP Tarsus Pharmaceuticals EC US87650L1035 55,768 4,726 9.26 1,516 -18.33 0.0309
2024-05-28 2024-03-31 NP Tarsus Pharmaceuticals EC US87650L1035 51,042 7,436 17.05 1,855 110.08 0.0387
2024-02-26 2023-12-31 NP Tarsus Pharmaceuticals EC US87650L1035 43,606 2,637 6.44 883 21.29 0.0188
2023-11-28 2023-09-30 NP Tarsus Pharmaceuticals EC US87650L1035 40,969 0 0.00 728 -1.62 0.0190
2023-08-25 2023-06-30 NP Tarsus Pharmaceuticals EC US87650L1035 40,969 10,672 35.22 740 94.74 0.0176
2023-05-26 2023-03-31 NP Tarsus Pharmaceuticals EC US87650L1035 30,297 0 0.00 381 -14.41 0.0101
2023-02-24 2022-12-31 NP Tarsus Pharmaceuticals EC US87650L1035 30,297 2,290 8.18 444 -7.31 0.0122
2022-11-25 2022-09-30 NP Tarsus Pharmaceuticals EC US87650L1035 28,007 0 0.00 479 17.40 0.0137
2022-08-25 2022-06-30 NP Tarsus Pharmaceuticals EC US87650L1035 28,007 16,119 135.59 409 105.03 0.0113
2022-05-26 2022-03-31 NP Tarsus Pharmaceuticals EC US87650L1035 11,888 0 0.00 200 -25.47 0.0047
2022-02-25 2021-12-31 NP Tarsus Pharmaceuticals EC US87650L1035 11,888 -5,213 -30.48 267 -27.45 0.0058
2021-11-24 2021-09-30 NP Tarsus Pharmaceuticals EC US87650L1035 17,101 0 0.00 369 -25.66 0.0081
2021-08-26 2021-06-30 NP Tarsus Pharmaceuticals EC US87650L1035 17,101 8,119 90.39 496 71.28 0.0106
2021-05-27 2021-03-31 NP Tarsus Pharmaceuticals EC US87650L1035 8,982 0 0.00 289 -22.10 0.0066
2021-02-25 2020-12-31 NP Tarsus Pharmaceuticals EC US87650L1035 8,982 8,982 371 0.0095
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.